More Than 55,000 Prescribers on the NextGen® Enterprise Network Will Have Immediate Access to OptimizeRx’s Point-of-Care Platform That Links the Pharma-Physician-Patient-Payor Continuum
ROCHESTER, Mich. – June 25, 2019 – OptimizeRx Corp. (Nasdaq: OPRX), a leading platform for digital health messaging in the pharmaceutical industry, is expected to join the Russell Microcap® and 3000® Indexes at the conclusion of the 2019 Russell i
ROCHESTER, Mich., May 08, 2019 (GLOBE NEWSWIRE)—OptimizeRx Corp. (NASDAQ: OPRX), a leading provider of digital health messaging for the pharmaceutical industry, reported results for the first quarter ended March 31, 2019. Quarterly comparisons...
Published on 04/30/2019..."Combined offering integrates EHR network and proactive patient services to improve access and adherence"
Stephen Silvestro Brings more than 20 Years’ Experience in Direct Operations, Sales, and Partner Network Growth, to Lead Revenue Activities and Strengthen the Go-to-Market
Published on Stocks News Now - Spring 2019 edition..."Patients are facing an increasing cost bur-den due to expensive medications, and record-high deductibles and co-pays."
ROCHESTER, Mich., April 23, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry, has been invited to present at three institutional investor conferences in May.
Published on MM&M on 04/03/2019..."Can pharma and payers align to promote better patient outcomes? What data infrastructure is necessary to demonstrate outcomes? OptimizeRx’s Miriam Paramore details the how and the why in this MM&M’s Spotlight...
Published on PM360 2/20/2019..."PM360 asked experts within point of care how the space is evolving and what might change in 2019 and beyond, including:
What has been the result of increased transparency and audited reporting after the controversy...
ROCHESTER, Mich., March 20, 2019 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (NASDAQ: OPRX), a leading digital health messaging platform for the pharmaceutical industry , released its full results and findings from its Drug Cost Survey. The survey...
